# Arcus Biosciences, Inc.: Form 8-K, filed Oct 21, 2026

- Company: [Arcus Biosciences, Inc.](/companies/rcus.md) (CIK 1724521)
- Form: 8-K
- Filed: 2026-10-21
- Accepted by EDGAR: Oct 21, 2026, 16:09 ET
- Period: 2026-10-21
- Accession: 0001193125-26-427829
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1724521/000119312526427829/d130368d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1724521/000119312526427829/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1724521/000119312526427829/d130368d8k.htm

Filed Oct 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-427829. Last ingested by Listed: Nov 4, 2026, 17:06 ET. No prices; not investment advice.
